• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4598324)   Today's Articles (1010)   Subscriber (49356)
Number Citation Analysis
151
Machtay M, Swann S, Komaki R, Byhardt R, Paulus R, Sause W, Curran W, Albain K, Movas B. O-041 What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80173-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
152
Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. PD-044 Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80377-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
153
Yom S, Liao Z, Liu H, Allen P, Chang J, Jeter M, Guerrero T, Stevens C, Cox J, Komaki R. O-152 Analysis of acute toxicity results of intensity modulated radiationtherapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80286-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
154
Liao Z, Komaki R, Milas L, Chen Y, Kies M, Chang J, Jeter M, Guerrero T, Blumenschein G, Cox J. P-959 A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81452-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
155
Komaki R, Swann S, Byhardt R, Cox J, Scott C, Sause W. PD-074 Does response rate in the induction chemotherapy predictsurvival for locally advanced non-small cell lung cancer (LANSCLC)?: Secondary analysis of RTOG 8804/8808. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80407-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
156
Chang J, Dong L, Mohan R, Liao Z, Cox J, Komaki R. PD-088 Image-guided proton radiotherapy for medically inoperable stage I non-small cell lung cancer. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80421-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
157
Machtay M, Swann S, Komaki R, Sause W, Langer C, Byhardt R, Curran W. O-042 Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80174-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
158
Ciangaru G, Tsunashima Y, Sakae T, Smith A, Mohan R, Starkschall G, Dong L, Komaki R, Akine Y, Cox J. SU-FF-T-340: Effect of Marker Implants On Dose Distribution in Proton Therapy. Med Phys 2005. [DOI: 10.1118/1.1998069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
159
Choi B, Balter P, Chi P, Zhang L, Dong L, Mohan R, Cox J, Komaki R, Liu H. SU-FF-J-29: Quantification of 4DCT Determined Lung Tumor Motion Based On Image Registration. Med Phys 2005. [DOI: 10.1118/1.1997575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
160
Swann RS, Machtay M, Komaki R, Sause WT, Langer CJ, Byhardt RW, Curran WJ. Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: An RTOG secondary analysis. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
161
Komaki R, Allen P, Glisson B, Lu C, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero T, Blumenschein G. Hyperfractionated/accelerated thoracic radiation therapy (HFXRT) increased survival compared to daily RT (QDRT) for limited small cell lung cancer (LSCLC) with Concurrent Chemotherapy (ChT). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7158] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
162
Werner-Wasik M, Swann S, Curran W, Robert F, Komaki R, Lee CP, Jafar S, Share R, Choy H, Blumenschein G. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 Trial. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7135] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
163
Lu C, Komaki R, Herbst RS, Evans WK, Lee JJ, Truong M, Moore CA, Choy H, Bleyer A, Fisch MJ. A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell Lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303): An interim report of toxicity and response. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7144] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
164
Sanders K, Guerrero T, Zhang Y, Tapia R, Cody D, Zhang G, Huang T, Komaki R, Price R. TU-EE-A3-06: Sub-Millimeter Three Dimensional Ventilation Imaging of Rodent Lungs. Med Phys 2005. [DOI: 10.1118/1.1998435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
165
Liu H, Wang X, Murshed H, Stevens C, Guerrero T, Balter P, Prado K, Liao Z, Chang J, Komaki R, Cox J, Mohan R. TU-E-T-6C-02: Clinical Implementation of IMRT for Lung Cancers. Med Phys 2005. [DOI: 10.1118/1.1999715] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
166
Wei X, Liu H, Jang S, Jauregui M, Dong L, Liao Z, Komaki R, Mohan R. SU-FF-T-380: Dose Mass Histogram and Its Application for 4D Treatment Planning. Med Phys 2005. [DOI: 10.1118/1.1998109] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
167
Kang Y, Zhang X, Wang H, Chang J, Liao Z, Komaki R, Cox J, Mohan R, Rosen I, Prado K, Balter P, Liu H, Dong L. WE-E-J-6C-06: Proton Treatment Planning for Mobile Lung Tumors. Med Phys 2005. [DOI: 10.1118/1.1998594] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
168
Liu H, Wei X, Jang S, Jauregui M, Dong L, Balter P, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Mohan R. SU-FF-J-22: Impact of Respiratory Motion On Dose Distributions and DVHs of Thoracic Structures - Evaluation Using 4DCT. Med Phys 2005. [DOI: 10.1118/1.1997568] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
169
Komaki R, Allen P, Glisson B, Milas L, Charles L, Kaplan B, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero T. Hyperfractionated and accelerated thoracic radiation therapy (HFXATRT) increased survival compared to daily TRT (QDTRT) for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.06.149] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
170
Shibuya K, Komaki R, Wu W, Shintani T, Itasaka S, Isobe T, Ryan A, Herbst R, O’Reilly M. Targeted therapy against VEGFR and EGFR signaling with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic mouse model of human non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.06.061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
171
Chen Y, Liao Z, Chen Y, Zhang Z, Jing J, Ajani J, Swisher S, Chang J, Guerrero T, Jeter M, Cox J, Komaki R. Treatment outcome of irradiated esophageal cancer. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.07.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
172
Sanders K, Guerrero T, Zhang G, Bilton S, Stevens C, Lu C, Stewart D, Komaki R. Quantitative measurement of regional tumor response to therapy. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.06.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
173
Phan AT, Rashid A, Luthra R, Lopez-Alvarez E, Swisher S, Komaki R, Bresalier R, Ajani JA. Molecular predictors of patients with localized upper gastrointestinal cancers after chemoradiation. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
174
Komaki R, Spitz MR, Wu X, Chang JY, Allen PK, Lika M, Fossella FV, Stevens CW, Liao Z, Cox JD. Mutagen Sensitivity (MS) may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
175
Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 2004;17:38-43. [PMID: 15209739 DOI: 10.1111/j.1442-2050.2004.00355.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
PrevPage 7 of 15 126781415Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA